Understanding Your Weekly Injection: Why Does My Wegovy Shot Sting?

Last reviewed: July 8, 2026

Last updated: July 8, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

When you start a weekly semaglutide injection, a mild stinging or burning sensation at the injection site is one of the most frequently reported experiences—affecting roughly 10-15% of patients in early treatment phases. Understanding why this happens and what you can do about it helps you stay committed to your personalized GLP-1 therapy without unnecessary worry.

Why GLP-1 Injection Site Stinging Occurs

Semaglutide is a naturally occurring peptide hormone that mimics glucagon-like peptide-1 in your body. When injected into subcutaneous tissue just beneath your skin, the medication can temporarily irritate nerve endings in that area, creating a localized stinging sensation that typically lasts a few seconds to a few minutes. This reaction is not an allergic response—it is the physical interaction between the liquid medication and your skin's sensory nerves.

The solution itself contains several inactive ingredients that help stabilize the semaglutide compound. These ingredients are generally well tolerated, but individual sensitivity varies based on skin thickness, hydration level, and nerve density at your injection site. Some patients experience no stinging at all, while others report a noticeable pinch or burn during the injection and for a brief moment afterward.

Room temperature matters more than many patients realize. Injecting cold medication directly from refrigeration can increase the likelihood and intensity of stinging. Additionally, rapid injection speed—pushing the plunger too quickly—can magnify the sensation because your tissue has less time to gradually accommodate the fluid volume.

How to Reduce Injection Site Discomfort

Bringing your semaglutide pen or syringe to room temperature 15-20 minutes before your injection is one of the simplest and most effective strategies. Remove it from the refrigerator and let it sit on your bathroom counter or nightstand. Warmer medication flows more smoothly through the needle and typically causes less localized irritation compared to cold solution.

Slow and steady injection technique makes a measurable difference. Instead of rapidly depressing the plunger, take 5-10 seconds to complete the injection. This gradual delivery allows your subcutaneous tissue to expand and accommodate the medication without triggering intense nerve activation. If you are using a pen device, press the button with steady, even pressure rather than a quick jab.

Choosing your injection site strategically can reduce discomfort over time. The abdomen, thighs, and upper arms are the approved rotation sites for semaglutide. Your abdomen typically has slightly thicker subcutaneous tissue and may feel less sensitive than inner thighs or areas with thinner skin. Rotate sites weekly to prevent repeated irritation in the same location and to reduce the buildup of scar tissue or lipohypertrophy.

When Stinging Signals a Bigger Problem

Mild stinging that resolves within a few minutes is normal and expected for many patients on compounded semaglutide therapy. However, burning that persists for hours, spreading redness, warmth, or swelling larger than one inch in diameter may indicate a localized infection or an unusual reaction to the injection. Contact your PlexusDx provider immediately if you develop these symptoms, fever, or pus at the injection site.

Severe pain during injection—described as shooting, electric, or unbearable—could mean the needle struck a nerve or blood vessel. This is rare but requires immediate attention. If you experience this type of acute pain, stop the injection, remove the needle, and apply gentle pressure with a clean bandage. Document which site this occurred on and inform your PlexusDx clinical team so they can recommend alternative injection locations for future doses.

PlexusDx medications are compounded at licensed 503A pharmacies using pharmaceutical-grade ingredients and rigorous quality standards. If you suspect a contamination issue or have an unexplained severe reaction, your provider can review your specific batch and work with the compounding pharmacy to investigate. Most injection site reactions resolve without intervention and do not require treatment discontinuation.

Personalization and Your Injection Experience

Everyone's body responds differently to injectable semaglutide based on genetics, skin physiology, and individual pain tolerance. PlexusDx offers the Precision Peptide Genetic Test—a peptide-pathway genetic analysis that examines how your body processes GLP-1 signaling and related hormonal pathways. Understanding your genetic profile helps your provider optimize your medication choice and dosing strategy to maximize efficacy while minimizing side effects like injection site irritation.

Your dose may need to go up as your body adjusts and you pursue deeper weight loss results. Your price won't. PlexusDx Semaglutide Injection is $189/mo month-to-month (or $149/mo on the 6-month plan) regardless of your dose level, with no membership fees or insurance requirements. This flat-rate model means you can titrate your medication upward—as is often medically necessary—without financial barriers. HSA and FSA accounts are accepted, making treatment accessible and affordable.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is the stinging during my semaglutide injection normal?

Yes, mild stinging or burning at the injection site is a normal response for many patients and typically lasts only a few seconds to minutes. It occurs because the medication temporarily irritates nerve endings in your skin. If discomfort is severe, persists for hours, or is accompanied by redness or swelling, contact your PlexusDx provider.

What does clinical evidence say about injection site reactions?

Clinical trials of semaglutide show that injection site reactions—including pain, redness, and swelling—occur in approximately 10-15% of patients during early treatment phases and typically decrease over time as your body adapts. Most reactions are mild and self-limiting, resolving within hours without medical intervention.

How much does PlexusDx compounded semaglutide cost?

PlexusDx Semaglutide Injection is $189/mo month-to-month (or $149/mo on the 6-month plan) and maintains that flat rate as your therapeutic dose increases—no membership fees, no insurance required. The medication is compounded by licensed 503A pharmacies and is eligible for HSA and FSA reimbursement.

Should I stop my injection if it stings?

Mild stinging is not a reason to discontinue therapy. Using room-temperature medication, injecting slowly, rotating sites, and applying ice beforehand all significantly reduce discomfort. If you experience severe, shooting pain or signs of infection, pause and contact your PlexusDx provider before your next dose.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

The Precision Peptide Genetic Test examines 49 peptides across 14 metabolic pathways and identifies genetic variants affecting GLP-1 and GLP-2 receptor sensitivity, as well as appetite-regulation genes. While this test does not directly predict injection site pain, it helps PlexusDx providers personalize your medication choice and dosing to optimize your treatment response and minimize unwanted reactions. The test is available for $99 as an add-on after your first month of treatment.

Related Reading

• Injection Wegovy
• Wegovy Shot
• Wegovy Injection Site
• Wegovy Injection

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.